Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, November 22 '25)

Image
By G.M.

 


    Clin Infect Dis

  1. LIANG C, Judy J, Chilson EL, Kelly SP, et al
    Estimating Risk of Guillain-Barre Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis.
    Clin Infect Dis. 2025 Nov 14:ciaf621. doi: 10.1093.
    PubMed         Abstract available

  2. ZUGER A
    Home testing for contagious illness: Historical context and modern caveats.
    Clin Infect Dis. 2025 Nov 14:ciaf623. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  3. AHMAD WA, Wolff-Sagy Y, Battat E, Arbel R, et al
    Mortality following recovery from COVID-19 hospitalization: a long-term cohort study.
    Int J Infect Dis. 2025 Nov 13:108223. doi: 10.1016/j.ijid.2025.108223.
    PubMed         Abstract available

  4. WANG C, Gao Y, Li W, Du J, et al
    Short-Term Risks of Influenza and COVID-19 Following Influenza Infection: A Self-Controlled Case Series Study.
    Int J Infect Dis. 2025 Nov 16:108221. doi: 10.1016/j.ijid.2025.108221.
    PubMed         Abstract available

  5. GARCIA-MARTINEZ DE ARTOLA D, Ciuffreda L, Lorenzo-Salazar JM, Munoz-Barrera A, et al
    A prolonged Delta SARS-CoV-2 infection during the Omicron wave in an HIV immunosuppressed patient.
    Int J Infect Dis. 2025 Nov 19:108233. doi: 10.1016/j.ijid.2025.108233.
    PubMed         Abstract available

  6. JO S, Lee S, Kim H, Won H, et al
    Effectiveness of the 2023-2024 monovalent XBB.1.5 vaccine against SARS-CoV-2 infection in people aged over 65 years in South Korea: A population-based cohort study.
    Int J Infect Dis. 2025 Nov 19:108238. doi: 10.1016/j.ijid.2025.108238.
    PubMed         Abstract available


    J Med Virol

  7. CHEN H, Li Z, Han X, Zhang S, et al
    Genetic Variants Specific to Critical COVID-19: Insights From Genome-Wide Association Studies and Structural Analysis.
    J Med Virol. 2025;97:e70719.
    PubMed         Abstract available

  8. ALI A, Courtney D, Broadbent L, Sharma P, et al
    Preclinical Screening Platform Identifies Azatadine-Dimaleate as a Potent Repurposed Therapeutic Against SARS-CoV-2 Infection.
    J Med Virol. 2025;97:e70713.
    PubMed         Abstract available

  9. BOUCETTA Y, Boschi C, Peroni E, Jean R, et al
    Co-Infection With Hepatitis E Virus and SARS-CoV-2 in a Lymphoma Patient.
    J Med Virol. 2025;97:e70706.
    PubMed         Abstract available

  10. TROTT G, Rover MM, Scolari FL, da Silva MMD, et al
    One-Year Quality of Life Among Survivors of Hospitalization for Omicron Infection in Brazil: A Multicentre Prospective Cohort Study.
    J Med Virol. 2025;97:e70687.
    PubMed         Abstract available

  11. KUMTHIP K, Yodmeeklin A, Khamrin P, Wadeesukkasem S, et al
    Molecular Epidemiology of Human Astroviruses and Emergence of HAstV4 in Pediatric Patients With Acute Gastroenteritis in Thailand During 2021-2024.
    J Med Virol. 2025;97:e70707.
    PubMed         Abstract available

  12. USHIJIMA H, Hoque SA, Hanaoka N, Yan H, et al
    Molecular Epidemiology of Adenoviruses and Emergence of HAdV-D56 in Pediatric Patients With Gastroenteritis in Japan From 2018 to 2023.
    J Med Virol. 2025;97:e70700.
    PubMed         Abstract available


    J Virol

  13. YUAN S, Wang J, Sang X, Xie Y, et al
    Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent in vitro and in vivo antiviral activities.
    J Virol. 2025 Nov 14:e0100125. doi: 10.1128/jvi.01001.
    PubMed         Abstract available

  14. JIN Q, Liu R, Wang W, Xie J, et al
    Increased pathogenicity and transmission of SARS-CoV-2 Omicron XBB.1.9 subvariants, including HK.3 and EG.5.1, relative to BA.2.
    J Virol. 2025 Nov 18:e0134225. doi: 10.1128/jvi.01342.
    PubMed         Abstract available

  15. CHEN C, Zhao L, Su N, Peng X, et al
    Bovine coronavirus enters HRT-18 cells via membrane fusion and clathrin-mediated endocytosis in a low pH-, dynamin-, cholesterol-, microtubule-, Rab7-, and Rab11-dependent manner.
    J Virol. 2025 Nov 18:e0127425. doi: 10.1128/jvi.01274.
    PubMed         Abstract available

  16. LUO Y, Gong Q-C, Yao Y-L, Chen Y, et al
    Swine acute diarrhea syndrome coronavirus-related viruses from bats show potential interspecies infection.
    J Virol. 2025 Nov 19:e0224024. doi: 10.1128/jvi.02240.
    PubMed         Abstract available


    JAMA

  17. PANT S
    2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants.
    JAMA. 2025 Nov 14. doi: 10.1001/jama.2025.19733.
    PubMed        


    Lancet

  18. ZIEGLER AG, Achenbach P, Weiss A, Berner R, et al
    Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial.
    Lancet. 2025 Nov 11:S0140-6736(25)01726-X. doi: 10.1016/S0140-6736(25)01726.
    PubMed         Abstract available


    Lancet Infect Dis

  19. MENTZER AJ, Smith GD, Lambe T, Knight JC, et al
    Time to tackle vaccine-HLA associations with artificial intelligence.
    Lancet Infect Dis. 2025 Nov 17:S1473-3099(25)00687.
    PubMed        

  20. ZHANG L, Chen N, Eichmann A, Nehlmeier I, et al
    Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2.
    Lancet Infect Dis. 2025 Nov 12:S1473-3099(25)00658.
    PubMed        

  21. ANYWAINE Z, Serwanga J, Ggayi AM, Abaasa AM, et al
    Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.
    Lancet Infect Dis. 2025 Nov 11:S1473-3099(25)00565.
    PubMed         Abstract available


    Nature

  22. HAUSDORFF WP
    How COVAX raced to protect the world from COVID-19.
    Nature. 2025;647:578-580.
    PubMed        


    Travel Med Infect Dis

  23. HEDRICH N, Lovey T, Bernhard J, Grobusch MP, et al
    Real-time illness monitoring in travellers: an international, prospective, digital surveillance study.
    Travel Med Infect Dis. 2025;68:102943.
    PubMed         Abstract available

  24. LEI Z, Lei Z, Wang Q
    Temporal and spatial dynamics of dengue fever in mainland China from 2004 to 2020 and the impact of COVID-19 public health interventions.
    Travel Med Infect Dis. 2025;68:102938.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »